Prospective Evaluation of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for Intravenous Immunoglobulin Resistance in a Large Cohort of Kawasaki Disease Patients
Authors:
- 2 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 39 (3) , 229-231
Abstract
The evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for intravenous immunoglobulin resistance prediction was prospectively performed in a large cohort of Kawasaki disease patients. It was found that the predictive values of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio, alone or combined, were not good enough although they were identified as independent risk factors for intravenous immunoglobulin resistance.Keywords
This publication has 9 references indexed in Scilit:
- A new model to predict intravenous immunoglobin-resistant Kawasaki diseaseOncotarget, 2017
- A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki diseasePLOS ONE, 2017
- The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki DiseaseThe Journal of Pediatrics, 2016
- Value of Neutrophil-Lymphocyte Ratio in Predicting Outcomes in Kawasaki DiseaseThe American Journal of Cardiology, 2015
- Neutrophil to lymphocyte ratio and cardiovascular diseases: a reviewExpert Review of Cardiovascular Therapy, 2013
- Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatmentEuropean Journal of Pediatrics, 2006
- Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki diseaseThe Journal of Pediatrics, 2006
- Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki DiseaseCirculation, 2006
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart AssociationPediatrics, 2004